Javascript must be enabled to continue!
Assessment of PAX6 alleles in 66 families with aniridia
View through CrossRef
We report on PAX6 alleles associated with a clinical diagnosis of classical aniridia in 81 affected individuals representing 66 families. Allelic variants expected to affect PAX6 function were identified in 61 families (76 individuals). Ten cases of sporadic aniridia (10 families) had complete (8 cases) or partial (2 cases) deletion of the PAX6 gene. Sequence changes that introduced a premature termination codon into the open reading frame of PAX6 occurred in 47 families (62 individuals). Three individuals with sporadic aniridia (three families) had sequence changes (one deletion, two run‐on mutations) expected to result in a C‐terminal extension. An intronic deletion of unknown functional significance was detected in one case of sporadic aniridia (one family), but not in unaffected relatives. Within these 61 families, single nucleotide substitutions accounted for 30/61 (49%), indels for 23/61 (38%), and complete deletion of the PAX6 locus for 8/61 (13%). In five cases of sporadic aniridia (five families), no disease‐causing mutation in the coding region was detected. In total, 23 unique variants were identified that have not been reported in the Leiden Open Variation Database (LOVD) database. Within the group assessed, 92% had sequence changes expected to reduce PAX6 function, confirming the primacy of PAX6 haploinsufficiency as causal for aniridia.
Title: Assessment of PAX6 alleles in 66 families with aniridia
Description:
We report on PAX6 alleles associated with a clinical diagnosis of classical aniridia in 81 affected individuals representing 66 families.
Allelic variants expected to affect PAX6 function were identified in 61 families (76 individuals).
Ten cases of sporadic aniridia (10 families) had complete (8 cases) or partial (2 cases) deletion of the PAX6 gene.
Sequence changes that introduced a premature termination codon into the open reading frame of PAX6 occurred in 47 families (62 individuals).
Three individuals with sporadic aniridia (three families) had sequence changes (one deletion, two run‐on mutations) expected to result in a C‐terminal extension.
An intronic deletion of unknown functional significance was detected in one case of sporadic aniridia (one family), but not in unaffected relatives.
Within these 61 families, single nucleotide substitutions accounted for 30/61 (49%), indels for 23/61 (38%), and complete deletion of the PAX6 locus for 8/61 (13%).
In five cases of sporadic aniridia (five families), no disease‐causing mutation in the coding region was detected.
In total, 23 unique variants were identified that have not been reported in the Leiden Open Variation Database (LOVD) database.
Within the group assessed, 92% had sequence changes expected to reduce PAX6 function, confirming the primacy of PAX6 haploinsufficiency as causal for aniridia.
Related Results
Molecular Genetics of Aniridia
Molecular Genetics of Aniridia
Abstract
Aniridia is a rare congenital disorder of eye development in which the characteristic feature is hypoplastic or absent i...
Functional conservation of Pax6 regulatory elements in humans and mice demonstrated with a novel transgenic reporter mouse
Functional conservation of Pax6 regulatory elements in humans and mice demonstrated with a novel transgenic reporter mouse
Abstract
Background
The Pax6 transcription factor is expressed during development in the eyes and in specific CNS regions, where it is essential ...
A rare missense PAX6 mutation causes atypical aniridia in a three-generation Chinese family
A rare missense PAX6 mutation causes atypical aniridia in a three-generation Chinese family
AIM: To investigate the molecular diagnosis of a three-generation Chinese family affected with aniridia, and further to identify clinically a PAX6 missense mutation in members with...
Differential role of Pax6 and its interaction with Shh–Gli1–IDH2 axis in regulation of glioma growth and chemoresistance
Differential role of Pax6 and its interaction with Shh–Gli1–IDH2 axis in regulation of glioma growth and chemoresistance
AbstractGlioma is a major brain tumor, and the associated mortality rate is very high. Contemporary therapies provide a chance of survival for 9–12 months. Therefore, a novel appro...
Meibomian gland dysfunction and keratopathy are associated with dry eye disease in aniridia
Meibomian gland dysfunction and keratopathy are associated with dry eye disease in aniridia
AimsTo investigate the aetiology and characteristics of dry eye disease (DED) in a Nordic cohort of patients with congenital aniridia.MethodsThirty-four Norwegian and one Danish su...
Jill Nerby and Aniridia Foundation International
Jill Nerby and Aniridia Foundation International
Jill Nerby was the first to welcome me to Aniridia Foundation International (AFI) when I joined. Shortly after beginning to volunteer for AFI’s members’ newsletter, I approached Ji...
Glaucoma and Frequency of Ocular and General Diseases in 30 Patients with Aniridia: A Clinical Study
Glaucoma and Frequency of Ocular and General Diseases in 30 Patients with Aniridia: A Clinical Study
Purpose
To evaluate the following in patients with aniridia: age at first examination at the University Eye Hospital and age at diagnosis of glaucoma; visual ac...
Family Pediatrics
Family Pediatrics
ABSTRACT/EXECUTIVE SUMMARYWhy a Task Force on the Family?The practice of pediatrics is unique among medical specialties in many ways, among which is the nearly certain presence of ...

